Effects of intravesical liposome-mediated human beta-defensin-2 gene transfection in a mouse urinary tract infection model

Microbiology and Immunology

Volumn 55, Issue 4, 2011, Pages 217-223

  Zhao, Junli ^a   Wang, Zhiping ^a   Chen, Xinnian ^a   Wang, Jianqin ^a   Li, Juan ^a  

^a LANZHOU UNIVERSITY   (China)

Author keywords

Gene therapy; Human defensin 2; Urinary tract infection

Indexed keywords

BETA DEFENSIN 2; LIPOSOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIUM COLONY; CELL CULTURE; COLONY FORMING UNIT; CONTROLLED STUDY; DNA TRANSFECTION; DNA TRANSFER; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO GENE TRANSFER; IN VIVO GENE TRANSFER; INFLAMMATORY INFILTRATE; LIPOSOMAL GENE DELIVERY SYSTEM; NONHUMAN; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE DRUG DOSE; SUPERNATANT; TRANSGENE; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI; WESTERN BLOTTING;

ADMINISTRATION, INTRAVESICAL; ANIMALS; BETA-DEFENSINS; CELL LINE; DISEASE MODELS, ANIMAL; FEMALE; GENE THERAPY; HUMANS; LIPOSOMES; MICE; RATS; RATS, WISTAR; TRANSFECTION; URINARY TRACT INFECTIONS;

ANIMALIA; BACTERIA (MICROORGANISMS); RATTUS;

EID: 79953087989     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2011.00315.x     Document Type: Article

References (23)

1. Foxman B. (2003) Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis Mon 49: 53-70.
2. Albert X., Huertas I., Pereiro, II., Sanfelix J., Gosalbes V., Perrota C. (2004) Antibiotics for preventing recurrent urinary tract infection in non-pregnant women. Cochrane Database Syst Rev 2004: CD001209.
3. Stamm W.E., Norrby S.R. (2001) Urinary tract infections: disease panorama and challenges. J Infect Dis 183(Suppl 1): S1-4.
4. Ali A.S., Townes C.L., Hall J., Pickard R.S. (2009) Maintaining a sterile urinary tract: the role of antimicrobial peptides. J Urol 182: 21-8.
5. Zasloff M. (2007) Antimicrobial peptides, innate immunity, and the normally sterile urinary tract. J Am Soc Nephrol 18: 2810-6.
6. Borregaard N., Elsbach P., Ganz T., Garred P., Svejgaard A. (2000) Innate immunity: from plants to humans. Immunol Today 21: 68-70.
7. De Smet K., Contreras R. (2005) Human antimicrobial peptides: defensins, cathelicidins and histatins. Biotechnol Lett 27: 1337-47.
8. Hancock R.E., Lehrer R. (1998) Cationic peptides: a new source of antibiotics. Trends Biotechnol 16: 82-8.
9. Yadava P., Zhang C., Sun J., Hughes J.A. (2006) Antimicrobial activities of human beta-defensins against Bacillus species. Int J Antimicrob Agents 28: 132-37.
10. Yang D., Chertov O., Bykovskaia S.N., Chen Q., Buffo M.J., Shogan J., Anderson M., Schroder J.M., Wang J.M., Howard O.M., Oppenheim J.J. (1999) Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 286: 525-28.
11. Oppenheim J.J., Biragyn A., Kwak L.W., Yang D. (2003) Roles of antimicrobial peptides such as defensins in innate and adaptive immunity. Ann Rheum Dis 62(Suppl 2): ii17-21.
12. Tani K., Murphy W.J., Chertov O., Salcedo R., Koh C.Y., Utsunomiya I., Funakoshi S., Asai O., Herrmann S.H., Wang J.M., Kwak L.W., Oppenheim J.J. (2000) Defensins act as potent adjuvants that promote cellular and humoral immune responses in mice to a lymphoma idiotype and carrier antigens. Int Immunol 12: 691-700.
13. Yang D., Liu Z.H., Tewary P., Chen Q., Rosa G., Oppenheim J.J. (2007) Defensin participation in innate and adaptive immunity. Curr Pharm Des 13: 3131-9.
14. Bals R., Weiner D.J., Moscioni A.D., Meegalla R.L., Wilson J.M. (1999) Augmentation of innate host defense by expression of a cathelicidin antimicrobial peptide. Infect Immun 67: 6084-9.
15. Yin C., Dang H.N., Gazor F., Huang G.T. (2006) Mouse salivary glands and human beta-defensin-2 as a study model for antimicrobial gene therapy: technical considerations. Int J Antimicrob Agents 28: 352-60.
16. Huang G.T., Zhang H.B., Kim D., Liu L., Ganz T. (2002) A model for antimicrobial gene therapy: demonstration of human beta-defensin 2 antimicrobial activities in vivo. Hum Gene Ther 13: 2017-25.
17. Shu Q., Shi Z., Zhao Z., Chen Z., Yao H., Chen Q., Hoeft A., Stuber F., Fang X. (2006) Protection against Pseudomonas aeruginosa pneumonia and sepsis-induced lung injury by overexpression of beta-defensin-2 in rats. Shock 26: 365-71.
18. Lin L.F., Zhu G., Yoo J.J., Soker S., Sukhatme V.P., Atala A. (2002) A system for the enhancement of adenovirus mediated gene transfer to uro-epithelium. J Urol 168: 813-18.
19. Hopkins W.J., Gendron-Fitzpatrick A., Balish E., Uehling D.T. (1998) Time course and host responses to Escherichia coli urinary tract infection in genetically distinct mouse strains. Infect Immun 66: 2798-802.
20. Miller D.G., Adam M.A., Miller A.D. (1990) Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 10: 4239-42.
21. Wu Q., Mahendran R., Esuvaranathan K. (2003) Nonviral cytokine gene therapy on an orthotopic bladder cancer model. Clin Cancer Res 9: 4522-8.
22. Horiguchi Y., Larchian W.A., Kaplinsky R., Fair W.R., Heston W.D. (2000) Intravesical liposome-mediated interleukin-2 gene therapy in orthotopic murine bladder cancer model. Gene Ther 7: 844-51.
23. Nitschke M., Wiehl S., Baer P.C., Kreft B. (2002) Bactericidal activity of renal tubular cells: the putative role of human beta-defensins. Exp Nephrol 10: 332-7.